The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126508761 12650876 1 I 20130916 20131022 20160815 20160815 PER US-JAZZ-2013-US-002496 JAZZ 16.77 YR M Y 107.94000 KG 20160815 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126508761 12650876 1 PS XYREM SODIUM OXYBATE 1 Oral 2.25 G, BID 3097762 21196 2.25 G ORAL SOLUTION
126508761 12650876 2 SS XYREM SODIUM OXYBATE 1 Oral 2.5 G, BID 21196 2.5 G ORAL SOLUTION
126508761 12650876 3 SS XYREM SODIUM OXYBATE 1 Oral 2.75 G, BID 21196 2.75 G ORAL SOLUTION
126508761 12650876 4 SS XYREM SODIUM OXYBATE 1 Oral 3 G, BID 21196 3 G ORAL SOLUTION
126508761 12650876 5 SS XYREM SODIUM OXYBATE 1 Oral 3.5 G, BID 3109214 21196 3.5 G ORAL SOLUTION
126508761 12650876 6 SS XYREM SODIUM OXYBATE 1 Oral 3.75 G, BID 3110636 21196 3.75 G ORAL SOLUTION
126508761 12650876 7 SS XYREM SODIUM OXYBATE 1 Oral 4 G, BID 3109219 21196 4 G ORAL SOLUTION
126508761 12650876 8 SS XYREM SODIUM OXYBATE 1 Oral 3 G, BID 21196 3 G ORAL SOLUTION
126508761 12650876 9 SS RITALIN METHYLPHENIDATE HYDROCHLORIDE 1 Oral 30 MG, QD Y 0 30 MG
126508761 12650876 10 SS RITALIN METHYLPHENIDATE HYDROCHLORIDE 1 Oral 60 MG, QD Y 0 60 MG
126508761 12650876 11 C EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 150 MG, U 0 150 MG
126508761 12650876 12 C EFFEXOR VENLAFAXINE HYDROCHLORIDE 1 U 0
126508761 12650876 13 C ABILIFY ARIPIPRAZOLE 1 Oral 30 MG, QD U 0 30 MG
126508761 12650876 14 C MODAFINIL. MODAFINIL 1 U 0
126508761 12650876 15 C RISPERDAL RISPERIDONE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126508761 12650876 1 Narcolepsy
126508761 12650876 2 Cataplexy
126508761 12650876 9 Narcolepsy
126508761 12650876 11 Rapid eye movements sleep abnormal
126508761 12650876 12 Anxiety
126508761 12650876 13 Affective disorder
126508761 12650876 14 Product used for unknown indication
126508761 12650876 15 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126508761 12650876 OT
126508761 12650876 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126508761 12650876 Agitation
126508761 12650876 Condition aggravated
126508761 12650876 Delusion
126508761 12650876 Hallucination, auditory
126508761 12650876 Hallucination, visual
126508761 12650876 Hypnagogic hallucination
126508761 12650876 Insomnia
126508761 12650876 Mood altered
126508761 12650876 Nightmare
126508761 12650876 Psychotic disorder
126508761 12650876 Sleep disorder
126508761 12650876 Suicide attempt
126508761 12650876 Thinking abnormal

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126508761 12650876 1 201207 2012 0
126508761 12650876 2 2012 2012 0
126508761 12650876 3 2012 2012 0
126508761 12650876 4 2012 0
126508761 12650876 5 201304 2013 0
126508761 12650876 6 201307 2013 0
126508761 12650876 7 2013 0
126508761 12650876 9 20130924 20130926 0
126508761 12650876 10 20130927 20130928 0